Announced
Completed
Hypera completed the acquisition of Buscopan brand from Boehringer Ingelheim for $319m.
Financials
Transaction Value£238m
Consideration TypeCash
Capital Owned-
Capital Bid For100%
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-
Sources
Tags
Brazil
Germany
Pharmaceuticals
Single Bidder
pharmaceuticals
Private
Acquisition
Friendly
Majority
Completed
Cross Border
Synopsis
Hypera, Brazilian pharmaceutical company, completed the acquisition of Buscopan brand from Boehringer Ingelheim, the second largest animal health business in the world, for $319m.
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
No credit card required
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.